Empiric Diagnosis and Treatment of Gastroesophageal Reflux in Infants Born Extremely Preterm and Associations with Growth and Development.
OBJECTIVE To examine the association of anti-reflux medication (ARM) for presumed gastroesophageal reflux (GER) with 2-year growth and development outcomes in infants born extremely preterm . STUDY DESIGN Cohort study of infants <27 weeks' gestation born between July 1, 2012, and December 31, 2019, who survived to 22...